SCHEMBL30890588

SCHEMBL30890588

[2H]N1CCC2(C1)Oc1nc(C)ccc1NC2=O

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 8/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890516 0.76 OTUD7B (0.39) OTUD7B
SCHEMBL13574265 0.71 BRD4 (0.37) OTUD7B
SCHEMBL30890770 0.70 LMNA (0.36) —
SCHEMBL27245141 0.70 OTUD7B (0.34) OTUD7B
SCHEMBL27244904 0.66 OTUD7B (0.37) OTUD7B
SCHEMBL27244758 0.65 OTUD7B (0.38) OTUD7B
SCHEMBL20608078 0.64 OTUD7B (0.56) OTUD7B
SCHEMBL1190887 0.62 MMP12 (0.46) —
SCHEMBL20608123 0.61 OTUD7B (0.66) OTUD7B
SCHEMBL24496560 0.60 MAPK14 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback